Veradigm | MDRX - Operating Expenses


Veradigm reported $188M in Operating Expenses for its fiscal quarter ending in December of 2022.





Operating Expenses Change Date
Alcidion AUD 23.27M 565K Dec/2025
Ambu A/S DKK 1.39B 75M Dec/2025
Amplifon EUR 539.04M 16.22M Sep/2025
Cardinal Health USD -2.88B 5M Dec/2025
Centene USD 50.96B 30.01B Dec/2025
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Cigna USD 41.71B 92.12M Dec/2025
Coloplast 5.19B 185M Dec/2025
Computer Programs Systems USD 207.2M 119.28M Dec/2025
Convatec Group USD 1B 518M Dec/2024
CVS Health USD 103.58B 3.66B Dec/2025
Diasorin EUR 224.05M 6.89M Sep/2025
Elevance Health USD 49.17B 5.21B Dec/2025
General Electric Aerospace USD 10.94B 7.87B Dec/2025
Gulf Medical Proj AED 182.97M 16.46M Dec/2025
Humana USD 33.32B 1.07B Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Laboratory Of America USD 3.13B 32.4M Dec/2025
Maximus USD 1.72B 524.26M Dec/2025
McKesson USD 104.5B 2.85B Dec/2025
Med Life RON 747.87M 6.92M Sep/2025
Molina Healthcare USD 11.53B 191M Dec/2025
Omnicell USD 312.8M 13.16M Dec/2025
Oriola-kd EUR 496.6M 39.9M Dec/2025
Owens Minor USD 708.15M 1.14B Dec/2025
Quest Diagnostics USD 2.42B 4.84B Dec/2025
Rede D'or Sao Luiz BRL 11.81B 129.96M Dec/2025
Siemens Healthineers EUR 4.73B 706M Dec/2025
Sonova Holding CHF 1.52B 59.9M Dec/2025
Supermax Corporation Bhd MYR 250.99M 97.72M Dec/2025
UnitedHealth USD 109.96B 1.11B Dec/2025
Veeva Systems USD 590.07M 19.69M Dec/2025
Veradigm USD 188M 61.08M Dec/2022
Xerox USD 365M 1.18B Sep/2025